Comparison of variant expression of estrogen receptor mRNA in normal breast tissue and breast cancer

International Journal of Oncology

Volumn 12, Issue 5, 1998, Pages 1025-1028

  Okada, Kaoru ^a   Ichii, Shigetoshi ^a   Hatada, Takuya ^a   Ishii, Hiromitsu ^a   Utsunomiya, Joji ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Alternative splicing; Breast cancer; Estrogen receptor; Estrogen receptor variants

Indexed keywords

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; EXON; FEMALE; GENE DELETION; GENETIC VARIABILITY; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031955734     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.5.1025     Document Type: Article

References (25)

1. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 240: 889-895, 1988.
2. Bocquel MT, Kumar V, Stricker C, Chambon P and Gronemeyer H: The contribution of the N-and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific. Nucleic Acids Res 17: 2581-2595, 1989.
3. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW and McDonnell DP: Human estrogen receptor transactivational capacity is determined by both cellular and promotor context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8: 21-30, 1994.
4. Walter P, Green S, Greene G, Krust A, Jensen E, Scrace G, Waterfield M and Chambom P: Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci USA 82: 7889-7893, 1985.
5. Ponglikitmongkol M, Green S and Chambon P: Genomic organization of the human oestrogen receptor gene. EMBO J 7: 3385-3388, 1985.
6. Hollenberg SM, Giguere V, Segui P and Evans RM: Colocalization of DNA binding and transcripion function in the human glucocorticoid receptor. Cell 49: 39-46, 1987.
7. Wang Y and Miksicek RJ: Identification of a dominant negative form of the human estrogen receptor. Mol Endocrinol 5: 1707-1715, 1991.
8. Fuqua SAW, Fitzgerald SD, Allred C, Elledge RM, Nafar RM, McDonnell DP, O'Malley BW, Green GL and McGuire WL: Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res 52: 483-486, 1992.
9. Fuqua SAW, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malley BW and McGuire WL: Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 51: 105-109, 1991.
10. Dotzlaw H, Alkahalaf M and Murphy LC: Characterization of estrogen receptor variant mRNAs from human breast cancers. Mol Endoclinol 6: 773-785, 1992.
11. 11; Ulrich P, Emanuela F, Giuseppe A, Alessandra F and Giorgio V: Alternative splicing of estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines. J Steroid Biochem Mol Biol 56: 99-105, 1996.
12. Walker KJ, McClelland RA, Candlish W, Blarney RW and Nicholson RI: Heterogeneity of oestrogen receptor expression in normal and malignant breast tissue. Eur J Cancer 1: 34-37, 1992.
13. McGuire WL, Chamness GC and Fuqua SAW: Abnormal estrogen receptor in clinical breast cancer. J Steroid Biochem Mol Biol 43: 243-247, 1992.
14. Leygue E, Watson PH and Murphy LC: Estfogen receptor variants in normal human mammary tissue. J Natl Cancer Inst 88: 284-290, 1996.
15. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform . extraction. Anal Biochem 162: 156-159, 1987.
16. Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532-534, 1993.
17. Sanger F, Nicklen S and Coulson AR: DNA sequencing with chain-terminating inhibition. Proc Natl Acad Sci USA 12: 5463-5467, 1977.
18. McCombie WR, Heiner C, Kelley JM, Fitzgerald MG and Gocayne JD: Rapid and reliable fluorescent cycle sequencing of double-stranded templates. DNA Sequence 2: 289-296, 1992.
19. Clarke R and Lippman ME: Antiestrogen resistance: mechanisms and reversal. In: Drug Resistance in Oncology. Teicher BA (ed.) New York, pp501-536, 1992.
20. Melchor JC, Rodriguez-Escudero FJ, Lujan S and Corcostegui B: Variation of estrogen and progesterone receptor status in breast cancer after tamoxifen therapy. Oncology 47: 467-470, 1990.
21. Clarke R, Thompson EW, Leonessa F, Lippman J, McGarvey M, Frandsen TL and Brunner N: Hormone resistance, invasiveness and metastatic potential in breast cancer. Breast Cancer Res Treat 24: 227-239, 1993.
22. Pfeffer U, Fecarotta E and Vidali .G: Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues in MCF-7 cells. Cancer Res 55: 2158-2165, 1995.
23. Dotzlaw H, Leygue E, Peter HW and Murphy LC: Expression of estrogen receptor-beta in human breast tumors. J Clin Endocrinol Metab 82: 2371-2374, 1996.
24. Mosselman S, Polman J and Dijkema R: ER beta: identification and characterization of a novel human estrogen receptor. Fed Eur Biochem Soc 392: 49-53, 1996.
25. Murphy LC, Dotzlaw H, Leygue E, Douglas D, Coutts A and Watson PH: Estrogen receptor variants and mutations. J Steroid Biochem Mol Biol 62: 363-372, 1997.